Life Science Conflict Grows from Stem Cells
The Harvard Crimson “Only a few years ago, former University President Lawrence H. Summers told alumni in Washington that Harvard could soon resemble Renaissance Florence. The...
The Harvard Crimson “Only a few years ago, former University President Lawrence H. Summers told alumni in Washington that Harvard could soon resemble Renaissance Florence. The...
The New York Times “In a striking instance of biologists’ new prowess at manipulating human cells, researchers at the Whitehead Institute in Cambridge, Mass., have converted...
Nature Reports “A new technique can differentiate more neurons from hES cells in less time.” Read More »
Nature, News in Brief “On 18 February, Seoul District Court in South Korea rejected a lawsuit about the egg-donation procedures used in the cloning research of...
Nature, Editor’s Summary “The discovery that non-germline adult cells can be reprogrammed to become pluripotent, able to differentiate into any cell type, opened up exciting possibilities.”...
Nature, News”Stephen Minger is one of the leading stem-cell scientists in the United Kingdom, known for his work both as a researcher and as a high-profile...
The Scientist: Newsblog “A neural stem cell transplant from fetal cells performed in Russia led to a brain tumor in a teenage boy, researchers in this...
Nature Reports Stem Cells “Haifan Lin directs the Stem Cell Center at Yale University in New Haven, Connecticut, where he uses genetics, cell biology and biochemistry...
CNN.com “A 42-year-old HIV patient with leukemia appears to have no detectable HIV in his blood and no symptoms after a stem cell transplant from a...
Science “For many California researchers, the bad news came just before the holidays: As a result of the state's deteriorating financial situation, the department of finance...
Nature News Researchers find problems in the strategy to create pluripotent cells from human-animal hybrid embryos. Read more »
Amednews.com [American Medical News] “Growing numbers of clinics abroad are marketing unproven, costly stem cell therapies to medical tourists and “exploiting patients’ hopes,” according to a...
Ars technica “The Obama administration wasted no time in overturning Bush-era executive orders, leaving many biologists excited by the prospect that current restrictions on human embryonic...
Science, Biotechnology News “Almost exactly 10 years after two groups isolated human embryonic stem cells, igniting tremendous hope for new cures, the cells are about to...
The Scientist, January 30, 2009 Read more »
Nature News “One of the world's biggest pharmaceutical companies is set to get even larger. Pfizer announced on 26 January that it intends to acquire Wyeth,...
Reuters “CHICAGO (Reuters) – U.S. researchers have reversed multiple sclerosis symptoms in early stage patients by using bone marrow stem cell transplants to reset the immune...
Nature News “US regulatory agency gives the go-ahead for first clinical trials of a human embryonic stem-cell treatment [by Geron].” Read more »
Time Magazine “Scientific inspiration can come from anywhere “Ó a person, an event, even an experiment gone awry. But perhaps nothing can drive innovation more powerfully...
NY Times “The United States Patent and Trademark Office has made a preliminary decision to revoke fundamental patents on human embryonic stem cells that some scientists...
Time, January 29, 2009 Read more »
On Tuesday, January 27th, Dr. Harold Varmus hosted a panel discussion on the future of stem cell research under the new Obama administration.
Scientific American, January 28, 2009 Read more »
NYSCF applauds the FDA approval of Geron’s pioneering human embryonic stem cell clinical trial which Tom Okarma, Geron’s president and CEO, and Hans Kierstead, of the...
January 23, 2009View Press Release »